SlideShare une entreprise Scribd logo
1  sur  7
Télécharger pour lire hors ligne
98 DISEASES OF THE COLON & RECTUM VOLUME 57: 1 (2014)
BACKGROUND: Colon resections are associated with
substantial risk for morbidity and readmissions, and
these have become markers for quality of care.
OBJECTIVE: The purpose of this study was to determine
risk factors for readmissions after elective colectomies to
improve patient care and better understand the complex
issues associated with readmissions.
DESIGN: This was an analysis of the prospective,
statewide, multicenter Michigan Surgical Quality
Collaborative database.
SETTINGS: The analysis was conducted at academic and
community medical centers in the state of Michigan.
PATIENTS: Elective laparoscopic and open ileocolic and
segmental colectomies from 2008 through 2010 were
included.
MAIN OUTCOME MEASURES: Univariate analysis and
a multivariate logistic regression model were used to
determine influence of patient characteristics, operative
factors, and postoperative complications on the incidence
of 30-day postoperative readmission.
RESULTS: The readmission rate among 4013 cases was
7.3% (N = 293). On the basis of multivariate logistic
regression, the top 3 significant risk factors associated
with readmission were stroke (OR, 10.0 [95%
CI, 2.70–37.0]; p = 0.001), venous thromboembolism
(OR, 6.5 [95% CI, 3.7–11.3]; p < 0.0001), and
organ-space surgical site infection (OR, 5.6 [95% CI,
3.4–9.4]; p < 0.0001). Important factors that contributed
to readmission risk but were not found to be independent
predictors of readmission included diabetes mellitus,
preoperative steroids, smoking, cardiac comorbidities, age
>80 years, anastomotic leaks, fascial dehiscence, sepsis,
pneumonia, unplanned intubation, and length of stay.
LIMITATIONS: The Michigan Surgical Quality
Collaborative is a large database, and true causal relations
are difficult to determine; reason for readmission is not
recorded in the database.
CONCLUSIONS: Postoperative complications account
for the majority of risk factors behind readmissions after
elective colectomy, whereas preoperative risk factors
have less direct influence. Current strategies addressing
readmission rates should focus on reducing preventable
complications.
KEY WORDS: Colon resection; Complications;
Postoperative readmissions, Risk factors.
C
olectomies are frequently performed procedures
with a high risk for complications and readmis-
sions.1–4
Unplanned readmissions after colon and
rectal operations can have serious consequences for pa-
tients4
and have a significant economic impact for health-
care providers. More recently, readmissions have gained
widespread interest among insurance companies, media,
and politicians as a quality indicator for medical and sur-
gical outcomes. With the introduction of the Hospital
Readmission Reduction Program by the Centers for Medi-
care & Medicaid Services in 2012, 30-day readmissions
Risk Factors for Readmission After Elective
Colectomy: Postoperative Complications Are More
Important Than Patient and Operative Factors
Therese G. Kerwel, M.D.1 2 1
Samantha K. Hendren, M.D.3 2 1
1 Division of Colon and Rectal Surgery, Spectrum Health, Grand Rapids, Michigan
2 Department of Surgery, St. Joseph Mercy Health System, Ann Arbor, Michigan
3 Department of Surgery, University of Michigan, Ann Arbor, Michigan
Dis Colon Rectum 2014; 57: 98–104
DOI: 10.1097/DCR.0000000000000007
© The ASCRS 2013
Financial Disclosure: None reported.
Podium presentation at the meeting of The American Society of Colon
and Rectal Surgeons, Phoenix, AZ, April 27 to May 1, 2013.
Correspondence: Therese G. Kerwel, M.D., 25 Michigan St NE, Suite
2200, Grand Rapids, MI 49503. E-mail: theresegannon@hotmail.com
ORIGINAL CONTRIBUTION
DISEASES OF THE COLON & RECTUM VOLUME 57: 1 (2014) 99
may also be subject to reduced reimbursement. Hospitals
with higher-than-predicted rates of readmissions may face
financial penalties, and almost half of large teaching hos-
pitals might be subjected to these cuts.5
Because of the enormous medical and financial im-
pacts of unplanned readmissions, numerous studies have
attempted to define risk factors for readmissions after colon
and rectal surgery. Despite numerous studies, widespread
disagreement remains in the medical literature regarding
whether there are modifiable risk factors for readmission
or whether it is largely unavoidable.6,7
None of those stud-
ies were able to delineate definitive strategies for readmis-
sion reduction,8
but all of them agree that the medical and
financial costs associated with this are high. Identifying
modifiable and/or avoidable factors in colon and rectal
surgery would have the potential to improve patient out-
comes and reduce health care-related costs. The aim of this
study was to identify risk factors that are independently as-
sociated with readmission within 30 days of elective colec-
tomy by analyzing the prospective, multicenter Michigan
Surgical Quality Collaborative (MSQC) database.
MATERIALS AND METHODS
The MSQC is a collaboration of 52 community and aca-
demic hospitals throughout the state of Michigan with
the goal to improve quality and patient outcomes.9
Sixty-
two percent of the participating hospitals are community
based without teaching activities.9
The MSQC database is
similar to the rigorously maintained American College of
Surgeons’ National Surgical Quality Improvement Pro-
gram (NSQIP).10,11
Collected data include >200 variables
and include patient demographic characteristics and co-
morbidities, preoperative and intraoperative measures,
and 30-day postoperative outcomes.11
The MSQC colecto-
my project involves 24 of the 52 hospitals and additionally
records procedure-specific perioperative data on patients
undergoing partial colectomy. Data for the MSQC are
meticulously recorded by NSQIP-certified clinical nurse
reviewers at each participating hospital. In case of miss-
ing or inconsistent data, the data abstractors communi-
cate directly with the operating surgeon. Readmissions
are tracked across all of the MSQC-participating hospitals
and are not limited to the hospital where the patient un-
derwent surgery.
All of the cases of elective laparoscopic and open il-
eocolic and segmental colectomies included as part of the
MSQC colectomy project from June 2008 through Novem-
ber 2010 were eligible for inclusion in our analysis. These
operations were defined by Current Procedural Terminol-
ogy codes 44140 and 44160 (open colectomy), as well as
44204 and 44205 (laparoscopic colectomy). The MSQC
database excludes patients with age <18 years, pregnant
women, trauma patients, and patients with ASA classes 5
and 6. Operations resulting in the creation of an ostomy,
rectal resections, or low anastomoses are not included in
the MSQC colectomy project. In addition, cases with com-
plete obstruction or perforation, as well as any emergent
cases, were also excluded from this study, because these are
not elective and risk factors are not modifiable.
To determine risk factors independently associated
with readmission within 30 days of the index operation,
patient characteristics, operative factors, and postopera-
tive complications recorded in the MSQC database were
first subjected to univariate analysis, determining the rela-
tionship of each variable to 30-day readmission. This was
followed by a multivariate logistic regression model, of
both preoperative and postoperative variables, which in-
cluded all of the variables with a p value of <0.10.Variables
with significance on each multivariate logistic regression
model were then entered into a final multivariate logistic
regression model that combined preoperative and postop-
erative variables to determine their independent influence
on the incidence of 30-day postoperative readmission.
RESULTS
From June 2008 through November 2010, 4013 cases met
inclusion criteria. Patient demographic characteristics
are shown in Table 1. Their average age was 64.2±15.0
years with a mean BMI of 28.5±8.3. The readmission rate
among these patients was 7.3% (N = 292).
Table 2 lists the preoperative variables studied. Uni-
variate analysis demonstrated a host of preoperative
factors with associations to readmission: 1) ASA class 4
(p = 0.02), 2) being functionally dependent (either par-
tial or total, p < 0.0001), 3) diabetes mellitus (p = 0.04),
4) hypertension (p = 0.003), 5) severe COPD (p = 0.02),
6) preoperative dyspnea (p = 0.001), 7) presence of an
open wound (p = 0.011), 8) steroids (p < 0.0001), 9)
TABLE 1. Demographics
Entire cohort (N = 4013) Readmit (N = 292) No readmit (N = 3721) p
N, % (n) 100 (4013) 7.28 (292) 92.72 (3721)
Age (mean ± SD), y 64.2±15.0 65.0±16.0 64.2±15.0 0.38
Age ≥80 y, % (n) 16.7 (672) 20.9 (61) 16.4 (611) 0.06
Men, % (n) 47.7 (1914) 51.0 (149) 47.4 (1765) 0.25
BMI, mean ± SD 28.5±8.3 28.7±6.9 28.5±8.4 0.26
Black, % (n) 11.3 (452) 12.0 (35) 11.2 (417) 0.70
KERWEL ET AL: RISK FACTORS FOR POSTOPERATIVE READMISSION100
known bleeding disorder (including congenital clotting
disorders and chronic anticoagulation, p < 0.0001), and
10) anemia (hematocrit <30%, p = 0.04). The readmis-
sion group was found to have, on average, more comor-
bid conditions as defined by MSQC than the no-readmit
group: 2.06±1.80 vs 1.57±1.50 (p = 0.0003). See the
bottom of Table 2 for a definition of these comorbid con-
ditions. A multiple logistic regression analysis of the pre-
operative variables with a p value of ≤0.10 was performed
to determine independent preoperative risk factors for
readmission. The only significant variable resulting from
this analysis was chronic preoperative steroid use (OR,
1.9 [95% CI, 1.14–3.19]; p = 0.014).
Tables 3 and 4 show preoperative laboratory data and
surgical variables studied. Factors on univariate analysis
that were found to have an association with readmission
are anemia (p = 0.04) and wound class 4 (p = 0.007). The
readmission group also had more intraoperative blood
loss than the no-readmit group (0.047). Laparoscopy
showed a trend with decreased readmission rates, but
this did not reach statistical significance. Wound class
4 was included in the analysis of preoperative variables
and found to be an independent predictor of readmission
(OR, 1.15; p = 0.0005)
Table 5 shows the postoperative outcomes studied.
The association between complications and readmission
is striking from a statistical standpoint, with the major-
ity of the complications being highly statistically signifi-
cant for their association with readmission. Univariate
analysis showed the following complications to be sig-
nificant: 1) return to the operating room within 30 days
(readmissions, 22.3%; no readmission, 3.6%; p < 0.0001),
2) anastomotic leak (12.8% vs 2.1%; p < 0.0001), 3) pro-
longed ileus (21.4% vs 6.1%; p < 0.0001), 4) sepsis (14.7%
TABLE 2. Preoperative variables and risk factors
Entire cohort
(N = 4013)
Readmit
(N = 292)
No readmit
(N = 3721) p
Total risk factors, mean ± SDa
1.78±1.7 2.06±1.8 1.57±1.5 <0.0001
Smoker, % (n) 18.7 (744) 12.1 (35) 19.2 (709) 0.004
Alcohol use, % (n) 3.2 (127) 2.1 (6) 3.3 (121) 0.38
Functionally dependent, % (n) 4.8 (193) 10.3 (30) 4.4 (163) <0.0001
ASA, % (n)
1 2.7 (108) 2.4 (7) 2.7 (101) 1.00
2 50.3 (2020) 46.2 (135) 50.7 (1885) 0.13
3 42.6 (1708) 44.2 (129) 42.4 (1579) 0.58
4 4.3 (174) 7.2 (21) 4.1 (153) 0.02
Hypertension, % (n) 56.4 (2245) 63.4 (184) 55.8 (2061) 0.003
Diabetes mellitus, % (n) 17.7 (709) 21.6 (63) 17.4 (646) 0.04
Dyspnea, % (n) 16.3 (649) 21.4 (62) 15.9 (587) 0.001
Cardiac disease, % (n) 13.9 (552) 17.2 (50) 13.6 (502) 0.09
Severe COPD, % (n) 5.8 (233) 8.6 (25) 5.6 (208) 0.016
CVA, % (n) 5.0 (200) 5.9 (17) 5.0 (183) 0.40
Bleeding disorder, % (n) 4.2 (168) 7.9 (23) 3.9 (145) <0.0001
TIA, % (n) 4.0 (160) 4.8 (14) 4.0 (146) 0.44
Steroid use, % (n) 3.7 (149) 7.6 (22) 3.4 (127) <0.0001
10% weight loss, % (n) 3.3 (131) 3.1 (9) 3.3 (122) 1.00
Disseminated cancer, % (n) 2.6 (102) 2.4 (7) 2.6 (95) 1.00
Open wound, % (n) 1.1 (42) 2.4 (7) 0.9 (35) 0.011
DNR, % (n) 1.0 (38) 1.4 (4) 0.9 (34) 0.35
CHF within 30 days, % (n) 1.0 (41) 1.7 (5) 1.0 (36) 0.12
PVD, % (n) 1.0 (40) 1.7 (5) 0.9 (35/3694) 0.21
Dialysis dependence, % (n) 0.8 (31) 0.7 (2) 0.8 (29/3694) 1.00
Ascites, % (n) 0.4 (16) 0.0 (0) 0.4 (16/3694) 0.62
Delirium, % (n) 0.2 (7) 0.3 (1) 0.2 (6/3694) 0.41
DNR = do not resuscitate; COPD = chronic obstructive pulmonary disease; CHF = congestive heart failure; PVD = peripheral vascular
disease; TIA = transient ischemic attack; CVA = cerebrovascular accident.
Bold p values indicate significance.
a
Subjects receive 1 point for each of the following preoperative risk factors as defined by the Michigan Surgical Quality
Collaborative: diabetes mellitus, preoperative sepsis, current smoker, >2 alcoholic drinks per day within 2 weeks, DNR status, ventila-
tor dependence within 48 hours, severe COPD, current pneumonia, ascites within 30 days, esophageal varices, CHF within 30 days,
history of myocardial infarction in the past 6 months, previous percutaneous coronary intervention/percutaneous transluminal
coronary angioplasty, previous cardiac surgery, angina within 30 days, hypertension requiring medication, history of revasculariza-
tion or amputation for PVD, rest pain/gangrene, acute renal failure within 24 hours, dialysis dependence, impaired sensorium within
48 hours, coma, hemiplegia/hemiparesis, history of TIAs, CVA with or without residual neurologic deficit, tumor involving central
nervous system, paraplegia/paraparesis, quadriplegia/quadriparesis, disseminated cancer, open wound, steroid use for chronic
condition, >10% loss of body weight in the last 6 months, ≥4 packed red blood cells preoperatively within 72 hours, chemotherapy
or radiotherapy within 90 days, sepsis within 48 hours, pregnancy, or previous operation within 30 days.
DISEASES OF THE COLON & RECTUM VOLUME 57: 1 (2014) 101
vs 3.1%; p < 0.0001), 5) septic shock (4.8% vs 1.0%; p
< 0.0001), 6) pneumonia (5.5% vs 2.1%; p < 0.0001), 7)
unplanned intubation (5.8% vs 2.4%; p < 0.0001), 8) or-
gan space surgical site infection ((SSI) 16.4% vs 1.6%; p
< 0.0001), 9) venous thromboembolism (9.2% vs 1.1%; p
< 0.0001), 10) Clostridium difficile colitis (5.5% vs 1.1%;
p < 0.0001), 11) mechanical bowel obstruction (6.6% vs
0.7%; p < 0.0001), 12) wound dehiscence (2.4% vs 0.8%;
p = 0.010), 13) acute myocardial infarction (3.1% vs 0.5%;
p < 0.0001), 14) cardiac arrest requiring cardiopulmonary
resuscitation (1.7% vs 0.6%; p = 0.024), 15) stroke (1.7%
vs 0.2%; p < 0.0001), 16) progressive renal insufficiency
(4.8% vs 0.5%; p < 0.0001), 17) superficial SSI (14.0% vs
5.1%; p < 0.0001), and 18) urinary tract infection (6.5%
vs 2.2%; p < 0.0001).
The postoperative variables with a p value of ≤0.10
were evaluated in a multiple logistic regression analysis
to determine which variables were independent risk fac-
tors. These are reoperation within 30 days, organ space
SSI, venous thromboembolism, Clostridium difficile coli-
tis, acute myocardial infarction, stroke, mechanical bowel
obstruction, prolonged ileus, urinary tract infection, and
superficial SSI. These postoperative variables were then
analyzed with preoperative steroid use in a combined
multilogistic regression analysis. This then identified risk
factors that independently predict readmission (Table 6):
1) postoperative stroke (OR, 10.01; p = 0.001), 2) postop-
erative venous thromboembolism (OR, 6.51; p < 0.0001),
3) organ space SSI (OR, 5.6; p < 0.0001), 4) postopera-
tive progressive renal insufficiency (OR, 3.95; p = 0.001),
5) postoperative Clostridium difficile colitis (OR, 3.61; p
< 0.0001), 6) reoperation within 30 days (OR, 3.12; p <
0.0001), 7) postoperative myocardial infarction (OR, 2.92;
p = 0.03), 8) postoperative mechanical bowel obstruction
(OR, 2.92; p = <0.0001), 9) superficial SSI (OR, 2.78; p <
0.0001), 10) prolonged ileus (OR, 2.23; p < 0.0001), and
11) urinary tract infection (OR, 1.9; p = 0.008). Preopera-
tive steroid use was no longer a significant risk factor when
analyzed with postoperative complications.
DISCUSSION
Major bowel resections have a high rate of patient re-
admission, with the majority (82%) occurring in the
first 30 days postoperatively.12,13
Thirty-day readmission
rates have become a marker of surgical quality and pos-
sible grounds for reimbursement penalties. As Centers for
Medicare & Medicaid Services attempts to involve read-
missions as a component of the total cost of an episode of
care, it is crucial that surgeons identify risk factors associ-
ated with readmissions.14
This analysis of a large series of
elective colectomies in multiple hospitals across the state
of Michigan demonstrated a readmission rate of 7.3%.
Although these results compare very favorably with fre-
quently reported 30-day readmission rates between 11.0%
and 13.7% after colorectal surgery,1,2,4
they confirm that
TABLE 4. Surgical variables
Cohort Readmit No readmit p
Type of surgery
Partial colectomy, % (n) 32.3 (1295) 36.6 (107) 31.9 (1188) 0.2
Right hemicolectomy, % (n) 19.9 (799) 19.9 (58) 19.9 (741) 1.00
Laparoscopic partial colectomy, % (n) 33.7 (1353) 30.1 (88) 34.0 (1265) 0.20
Laparoscopic right hemicolectomy, % (n) 14.1 (565) 13.3 (39) 14.1 (526) 0.79
Laparoscopy, % (n) 47.8 (1918) 43.5 (127) 48.1 (1791) 0.13
Intraoperative blood loss (mean ± SD), mL 137±220 156±180 135±171 0.047
Wound class, % (n)
2 86.6 (3474) 81.2 (237) 87.0 (3237) 0.007
3 9.9 (398) 12.3 (36) 9.7 (362) 0.16
4 3.5 (139) 6.5 (19) 3.2 (120) 0.0069
Bold p values indicate significance.
TABLE 3. Selected laboratory values
Cohort Readmit No readmit p
Anemia (Hct <30%), % (n) 9.4 (362) 12.5 (35) 9.2 (327) 0.036
Mean Hct (mean ± SD), % 38.0±5.8 37.2±5.9 38.1±5.8 0.013
Preoperative glucose (mean ± SD), mg/dL 111±38 114±37 111±38 0.218
Intraoperative glucose, mean ± SD 158±58 166±51 157±59 0.47
Glucose POD1, mean ± SD 143±44 147±52 143±43 0.17
Glucose POD2, mean ± SD 126±37 128±38 126±37 0.46
Hct = hematocrit; POD = postoperative day.
Bold p values indicate significance.
KERWEL ET AL: RISK FACTORS FOR POSTOPERATIVE READMISSION102
readmissions are indeed a problem. Although the 30-day
mortality rate in patients who were readmitted was not
significantly higher than in patients who did not return to
the hospital (2.1% vs 1.7%; p = 0.64), other studies have
shown worse long-term outcomes at 1 year, especially
among cancer patients.1,4
In our multivariate analysis, we demonstrated that
postoperative complications accounted for the majority of
risk factors that were independently associated with 30-
day readmissions. Although not all postoperative compli-
cations are avoidable, this factor may be more amenable to
strategies aimed to reduce preventable complications than
patient factors and comorbidities, because many patient
factors cannot be modified in the preoperative period
before colon resection. The strong association between
readmissions and postoperative complications has been
shown before in other studies.1,2,15,16
Of interest, the article
by Kassin et al16
reached the same conclusions that we have
using a similar analysis with similar methodology for gen-
eral surgery patients.
The complications with the highest incidence in our
cohort were prolonged ileus (7.2%), superficial SSI (5.7%),
sepsis (4.0%), anastomotic leak (3.3%), and organ space
SSI (2.6%). All of the other complications related to read-
missions had an incidence of well below 3%. These data
suggest that an effort to reduce those complications might
reduce readmission rates. A reduction in prolonged ileus
has been shown with narcotic-sparing enhanced recov-
ery pathways (ERPs) and use of minimally invasive tech-
niques.17–19
As more high-quality studies become available
TABLE 5. Postoperative outcomes
Cohort Readmits No readmits p
In-hospital death, % (n) 1.7 (70) 2.1 (6) 1.7 (64) 0.64
Prolonged ileus, % (n) 7.2 (285) 21.4 (62) 6.1 (223) <0.0001
SSI–superficial, % (n) 5.7 (230) 14.0 (41) 5.1 (189) <0.0001
Return to OR within 30 days, % (n) 4.9 (197) 22.3 (66) 3.6 (132) <0.0001
Sepsis, % (n) 4.0 (159) 14.7 (43) 3.1 (116) <0.0001
Anastomotic leak, % (n) 3.3 (113) 12.8 (37) 2.1 (76) <0.0001
Unplanned intubation, % (n) 2.6 (105) 5.8 (17) 2.4 (88) <0.0001
SSI–organ space, % (n) 2.6 (106) 16.4 (48) 1.6 (58) <0.0001
UTI, % (n) 2.5 (100) 6.5 (19) 2.2 (81) <0.0001
Pneumonia, % (n) 2.4 (95) 5.5 (16) 2.1 (79) <0.0001
VTE, % (n) 1.7 (69) 9.2 (27) 1.1 (42) <0.0001
Clostridium difficile colitis, % (n) 1.4 (58) 5.5 (16) 1.1 (42) <0.0001
Septic shock, % (n) 1.2 (50) 4.8 (14) 1.0 (36) <0.0001
Mechanical obstruction, % (n) 1.1 (43) 6.6 (19) 0.7 (24) <0.0001
Wound dehiscence, % (n) 1.0 (39) 2.4 (7) 0.8 (32) 0.010
Progressive renal insufficiency, % (n) 0.8 (33) 4.8 (14) 0.5 (19) <0.0001
SSI–deep space, % (n) 0.7 (30) 1.0 (3) 0.7 (27) 0.48
Acute myocardial infarction, % (n) 0.7 (29) 3.1 (9) 0.5 (20) <0.0001
Cardiac arrest, % (n) 0.7 (28) 1.7 (5) 0.6 (23) 0.024
Acute renal failure, % (n) 0.6 (23) 1.0 (3) 0.5 (20) 0.23
Stroke, % (n) 0.3 (11) 1.7 (5) 0.2 (6) <0.0001
Median length of stay, days 5 (0–82) 6 (1–58) 5 (0–82)
SSI = surgical site infection; OR = operating room; UTI = urinary tract infection; VTE = venous thromboembolism.
Bold p values indicate significance.
TABLE 6. Risk factors for readmission based on multivariate analysis
OR 95% CI, lower 95% CI, upper p
Postoperative CVA 10.0 2.70 37.0 0.001
Postoperative VTE 6.51 3.75 11.31 <0.0001
Organ space SSI 5.63 3.38 9.37 <0.0001
Postoperative progressive renal insufficiency 3.95 1.74 8.94 0.001
Postoperative Clostridium difficile colitis 3.61 1.81 7.18 <0.0001
Postoperative reoperation 3.12 2.03 4.79 <0.0001
Superficial SSI 2.78 1.87 4.16 <0.0001
Postoperative mechanical bowel obstruction 2.92 1.35 6.33 0.007
Postoperative acute myocardial infarction 2.92 1.12 7.57 0.028
Prolonged ileus 2.23 1.53 3.24 <0.0001
Postoperative UTI 1.89 1.05 3.38 0.033
CVA = cerebrovascular accident; SSI = surgical site infection; UTI = urinary tract infection; VTE = venous thromboembolism.
Bold p values indicate significance.
DISEASES OF THE COLON & RECTUM VOLUME 57: 1 (2014) 103
demonstrating the superiority of ERPs over the conven-
tional postoperative management of colorectal patients, a
continuing decrease in prolonged ileus may be seen. How-
ever, reducing the rate of superficial SSIs has proven to be a
difficult task despite tremendous effort on the part of physi-
cians and hospitals. Although process measures such as the
Surgical Care Improvement Program were introduced to
reduce infectious complications after surgery and are now
considered standard of care, the ability of these measures
to actually improve outcomes is highly controversial.15,20,21
This leads to the more general question of how to ap-
proach complications in colorectal surgery that are difficult
to impact.Similar to superficial SSIs,anastomotic leaks have
been studied extensively, but undisputed risk factors and
strategies to avoid them, short of avoiding an anastomosis,
remain elusive.Penalization for readmission related to some
complications may, therefore, not be the right approach.
Notably, several important patient-related factors, such
as age,diabetes mellitus,and cardiac comorbidities were not
found to be independent predictors of 30-day readmission,
although they must contribute to some degree by increasing
the risk for complications. In contrast to our study, Schnei-
der et al1
found patient-related factors such as older age and
severity of comorbidities to be important predictors, and
Wick et al2
found an association between a longer initial
length of stay (LOS (>7 days)) and readmission. Although
we did not find that older age was a risk factor, our data
do indicates that accumulating risk factors puts a patient at
risk for readmission (OR, 1.22), although not to the degree
that postoperative complications do (Table 6). The chain of
events among preoperative risk factors, postoperative com-
plications, and readmission is difficult to unravel. For many
patient factors and complications, this degree of correlation
between preoperative risk factors and postoperative com-
plications will always remain unclear, and any analysis of a
database that collects preoperative and postoperative data,
such as the NSQIP, does not allow us to completely unravel
this chain of events.This is a limitation that our study shares
with other recent similar analyses1-3
on readmission, as well
as most studies involving the NSQIP in general.1,16,22
The
commonly used methodology of performing univariate fol-
lowed by multivariate analysis aims to reduce confounding
factors but cannot completely exclude them.
Our results did not demonstrate an association be-
tween LOS and readmission rate. This finding is particu-
larly interesting in light of the increasing introduction of
ERPs, which have been shown to lead to a reduction in
LOS but have raised concerns about increased complica-
tions and readmission rates. These findings are consistent
with an increasing number of studies that confirm the
safety of ERPs.3,8,17–19,23
When discussing these findings, several strengths and
limitations of our study methodology have to be consid-
ered. Our results are derived from a thoroughly main-
tained multicenter database that adheres to strict data
recording and quality standards. We analyzed a compre-
hensive list of variables for their association with post-
operative readmission, many of which would be difficult
or impossible to assess in a randomized clinical trial. Be-
cause of its inclusion of a wide variety of hospitals, from a
rural community to large university hospitals, our patient
population may be considered representative of a real-
world patient care setting. Nevertheless, this study comes
with the limitations associated with any database analy-
sis, and true causal relations cannot be determined. The
MSQC database does not record reasons for readmissions
within 30 days, and, therefore, it is not possible to deter-
mine whether some readmissions were planned. In addi-
tion, our findings might be influenced by current surgical
practices in the state of Michigan, which may limit their
national generalizability.
In summary, postoperative complications account
for the majority of risk factors behind readmissions after
elective colectomy, whereas preoperative, patient-related
risk factors have less direct influence. Current strategies
addressing readmission rates should focus on reducing
preventable complications while still accepting that much
may not be completely avoidable. In addition, the issue of
readmission may need to be refocused on defining accept-
able rates of complications instead of widespread policies
aimed at penalizing all readmissions.
REFERENCES
1. Schneider EB, Hyder O, Brooke BS, et al. Patient readmission
and mortality after colorectal surgery for colon cancer: impact
of length of stay relative to other clinical factors. J Am Coll Surg.
2012;214:390–398.
2. Wick EC, Shore AD, Hirose K, et al. Readmission rates
and cost following colorectal surgery. Dis Colon Rectum.
2011;54:1475–1479.
3. Hendren S, Morris AM, Zhang W, Dimick J. Early discharge and
hospital readmission after colectomy for cancer. Dis Colon Rec-
tum. 2011;54:1362–1367.
4. Greenblatt DY, Weber SM, O’Connor ES, LoConte NK, Liou
JI, Smith MA. Readmission after colectomy for cancer predicts
one-year mortality. Ann Surg. 2010;251:659–669.
5. Joynt KE, Jha AK. Characteristics of hospitals receiving pen-
alties under the Hospital Readmissions Reduction Program.
JAMA. 2013;309:342–343.
6. Joynt KE, Jha AK. Thirty-day readmissions: truth and conse-
quences. N Engl J Med. 2012;366:1366–1369.
7. van Walraven C, Bennett C, Jennings A, Austin PC, Forster AJ.
Proportion of hospital readmissions deemed avoidable: a sys-
tematic review. CMAJ. 2011;183:E391–E402.
8. O’Brien DP, Senagore A, Merlino J, Brady K, Delaney C. Predic-
tors and outcome of readmission after laparoscopic intestinal
surgery. World J Surg. 2007;31:2430–2435.
9. Campbell DA Jr, Kubus JJ, Henke PK, Hutton M, Englesbe MJ.
The Michigan Surgical Quality Collaborative: a legacy of Shukri
Khuri. Am J Surg. 2009;198(suppl):S49–S55.
KERWEL ET AL: RISK FACTORS FOR POSTOPERATIVE READMISSION104
10. Fink AS, Campbell DA Jr, Mentzer RM Jr, et al. The National
Surgical Quality Improvement Program in non-veterans ad-
ministration hospitals: initial demonstration of feasibility. Ann
Surg. 2002;236:344–353.
11. Khuri SF, Daley J, Henderson W, et al. The Department of Vet-
erans Affairs’ NSQIP: the first national, validated, outcome-
based, risk-adjusted, and peer-controlled program for the
measurement and enhancement of the quality of surgical care.
National VA Surgical Quality Improvement Program. Ann Surg.
1998;228:491–507.
12. Azimuddin K, Rosen L, Reed JF 3rd, Stasik JJ, Riether RD,
Khubchandani IT. Readmissions after colorectal surgery cannot
be predicted. Dis Colon Rectum. 2001;44:942–946.
13. Jencks SF, Williams MV, Coleman EA. Rehospitalizations
among patients in the Medicare fee-for-service program. N Engl
J Med. 2009;360:1418–1428.
14. Birkmeyer JD, Gust C, Baser O, Dimick JB, Sutherland JM, Skin-
ner JS. Medicare payments for common inpatient procedures:
implications for episode-based payment bundling. Health Serv
Res. 2010;45:1783–1795.
15. Berenguer CM, Ochsner MG Jr, Lord SA, Senkowski CK. Im-
proving surgical site infections: using National Surgical Quality
Improvement Program data to institute Surgical Care Improve-
ment Project protocols in improving surgical outcomes. J Am
Coll Surg. 2010;210:737–41, 741.
16. Kassin MT, Owen RM, Perez SD, et al. Risk factors for 30-day
hospital readmission among general surgery patients. J Am Coll
Surg. 2012;215:322–330.
17. Jorgensen H, Wetterslev J, Moiniche S, Dahl JB. Epidural lo-
cal anaesthetics versus opioid-based analgesic regimens
on postoperative gastrointestinal paralysis, PONV and
pain after abdominal surgery. Cochrane Database Syst Rev.
2000;(4):CD001893.
18. Li MZ, Xiao LB, Wu WH, Yang SB, Li SZ. Meta-analysis of lapa-
roscopic versus open colorectal surgery within fast-track peri-
operative care. Dis Colon Rectum. 2012;55:821–827.
19. Vlug MS, Wind J, Hollmann MW, et al.; LAFA study group.
Laparoscopy in combination with fast track multimodal man-
agement is the best perioperative strategy in patients undergo-
ing colonic surgery: a randomized clinical trial (LAFA-study).
Ann Surg. 2011;254:868–875.
20. Garcia N, Fogel S, Baker C, Remine S, Jones J. Should com-
pliance with the Surgical Care Improvement Project (SCIP)
process measures determine Medicare and Medicaid reim-
bursement rates? Am Surg. 2012;78:653–656.
21. Ingraham AM, Cohen ME, Bilimoria KY, et al. Associa-
tion of surgical care improvement project infection-related
process measure compliance with risk-adjusted outcomes:
implications for quality measurement. J Am Coll Surg.
2010;211:705–714.
22. Schneider EB, Hyder O, Wolfgang CL, et al. Patient readmission
and mortality after surgery for hepato-pancreato-biliary malig-
nancies. J Am Coll Surg. 2012;215:607–615.
23. KolozsvariNO,CaprettiG,KanevaP,etal.Impactof anenhanced
recovery program on short-term outcomes after scheduled lap-
aroscopic colon resection. Surg Endosc. 2013;27:133–138.

Contenu connexe

Tendances

Has Survival following Pancreaticoduodenectomy for Pancreas (Print)
Has Survival following Pancreaticoduodenectomy for Pancreas (Print)Has Survival following Pancreaticoduodenectomy for Pancreas (Print)
Has Survival following Pancreaticoduodenectomy for Pancreas (Print)Ahmed Salem MD
 
best practice NMBRA GIST
best practice NMBRA GISTbest practice NMBRA GIST
best practice NMBRA GISTNHS
 
RESEARCH PRAPOSAL
RESEARCH PRAPOSALRESEARCH PRAPOSAL
RESEARCH PRAPOSALpankaj rana
 
Colorectal cancer screening and computerized tomographic colonography
Colorectal cancer screening and computerized tomographic colonographyColorectal cancer screening and computerized tomographic colonography
Colorectal cancer screening and computerized tomographic colonographySpringer
 
10 joyce neumann
10 joyce neumann10 joyce neumann
10 joyce neumannspa718
 
Geriatric Cardio-Oncology
Geriatric Cardio-OncologyGeriatric Cardio-Oncology
Geriatric Cardio-OncologyCamilla Wong
 
Current Role of Surgery in Endometriosis; Indications and Progress
Current Role of Surgery in Endometriosis; Indications and ProgressCurrent Role of Surgery in Endometriosis; Indications and Progress
Current Role of Surgery in Endometriosis; Indications and ProgressCrimsonpublisherssmoaj
 
G112 Ito & Shiromaru (2009). Patients’ coping strategies before and after ab...
G112  Ito & Shiromaru (2009). Patients’ coping strategies before and after ab...G112  Ito & Shiromaru (2009). Patients’ coping strategies before and after ab...
G112 Ito & Shiromaru (2009). Patients’ coping strategies before and after ab...Takehiko Ito
 
Management of pediatric blunt renal trauma a systematic review
Management of pediatric blunt renal trauma  a systematic reviewManagement of pediatric blunt renal trauma  a systematic review
Management of pediatric blunt renal trauma a systematic reviewskrentz
 
EFFICACY OF FIXED VERSUS REMOVAL RETAINER POST ORTHODONTIC TREATMENT: A COMP...
 EFFICACY OF FIXED VERSUS REMOVAL RETAINER POST ORTHODONTIC TREATMENT: A COMP... EFFICACY OF FIXED VERSUS REMOVAL RETAINER POST ORTHODONTIC TREATMENT: A COMP...
EFFICACY OF FIXED VERSUS REMOVAL RETAINER POST ORTHODONTIC TREATMENT: A COMP...DrHeena tiwari
 
Gastro Esophageal Reflux Disease
Gastro Esophageal Reflux DiseaseGastro Esophageal Reflux Disease
Gastro Esophageal Reflux DiseaseApollo Hospitals
 
June 2016 IEP
June 2016 IEPJune 2016 IEP
June 2016 IEPskrentz
 
125321274 peritoneal-carcinomatosis-grand-case-study
125321274 peritoneal-carcinomatosis-grand-case-study125321274 peritoneal-carcinomatosis-grand-case-study
125321274 peritoneal-carcinomatosis-grand-case-studyhomeworkping9
 

Tendances (20)

Has Survival following Pancreaticoduodenectomy for Pancreas (Print)
Has Survival following Pancreaticoduodenectomy for Pancreas (Print)Has Survival following Pancreaticoduodenectomy for Pancreas (Print)
Has Survival following Pancreaticoduodenectomy for Pancreas (Print)
 
best practice NMBRA GIST
best practice NMBRA GISTbest practice NMBRA GIST
best practice NMBRA GIST
 
RESEARCH PRAPOSAL
RESEARCH PRAPOSALRESEARCH PRAPOSAL
RESEARCH PRAPOSAL
 
Muhannad Hafi MD
Muhannad Hafi MDMuhannad Hafi MD
Muhannad Hafi MD
 
Oncoplasticpaper
OncoplasticpaperOncoplasticpaper
Oncoplasticpaper
 
Colorectal cancer screening and computerized tomographic colonography
Colorectal cancer screening and computerized tomographic colonographyColorectal cancer screening and computerized tomographic colonography
Colorectal cancer screening and computerized tomographic colonography
 
Cga
CgaCga
Cga
 
10 joyce neumann
10 joyce neumann10 joyce neumann
10 joyce neumann
 
Geriatric Cardio-Oncology
Geriatric Cardio-OncologyGeriatric Cardio-Oncology
Geriatric Cardio-Oncology
 
Sages Guideline on Endoluminal Surgery
Sages Guideline on Endoluminal SurgerySages Guideline on Endoluminal Surgery
Sages Guideline on Endoluminal Surgery
 
NYP EBP Cohort 8 Under Pressure
NYP EBP Cohort 8 Under PressureNYP EBP Cohort 8 Under Pressure
NYP EBP Cohort 8 Under Pressure
 
Current Role of Surgery in Endometriosis; Indications and Progress
Current Role of Surgery in Endometriosis; Indications and ProgressCurrent Role of Surgery in Endometriosis; Indications and Progress
Current Role of Surgery in Endometriosis; Indications and Progress
 
G112 Ito & Shiromaru (2009). Patients’ coping strategies before and after ab...
G112  Ito & Shiromaru (2009). Patients’ coping strategies before and after ab...G112  Ito & Shiromaru (2009). Patients’ coping strategies before and after ab...
G112 Ito & Shiromaru (2009). Patients’ coping strategies before and after ab...
 
Management of pediatric blunt renal trauma a systematic review
Management of pediatric blunt renal trauma  a systematic reviewManagement of pediatric blunt renal trauma  a systematic review
Management of pediatric blunt renal trauma a systematic review
 
zhe_CRI2015_NHANES
zhe_CRI2015_NHANESzhe_CRI2015_NHANES
zhe_CRI2015_NHANES
 
EFFICACY OF FIXED VERSUS REMOVAL RETAINER POST ORTHODONTIC TREATMENT: A COMP...
 EFFICACY OF FIXED VERSUS REMOVAL RETAINER POST ORTHODONTIC TREATMENT: A COMP... EFFICACY OF FIXED VERSUS REMOVAL RETAINER POST ORTHODONTIC TREATMENT: A COMP...
EFFICACY OF FIXED VERSUS REMOVAL RETAINER POST ORTHODONTIC TREATMENT: A COMP...
 
Gastro Esophageal Reflux Disease
Gastro Esophageal Reflux DiseaseGastro Esophageal Reflux Disease
Gastro Esophageal Reflux Disease
 
Git j club covid endoscopy21
Git j club covid endoscopy21Git j club covid endoscopy21
Git j club covid endoscopy21
 
June 2016 IEP
June 2016 IEPJune 2016 IEP
June 2016 IEP
 
125321274 peritoneal-carcinomatosis-grand-case-study
125321274 peritoneal-carcinomatosis-grand-case-study125321274 peritoneal-carcinomatosis-grand-case-study
125321274 peritoneal-carcinomatosis-grand-case-study
 

Similaire à Risk factors for readmission after elective colectomy postoperative complications are more important than patient and operative factors

AC Chemo CRC ASCO Poster
AC Chemo CRC ASCO PosterAC Chemo CRC ASCO Poster
AC Chemo CRC ASCO PosterMaha Hassan
 
Journal readingg
Journal readinggJournal readingg
Journal readinggmichelle mi
 
ERAS and regional anesthesia at PGA 2015
ERAS and regional anesthesia at PGA 2015ERAS and regional anesthesia at PGA 2015
ERAS and regional anesthesia at PGA 2015Colin McCartney
 
15 April 2013Page of 1 ProQuest___________________________.docx
15 April 2013Page   of 1 ProQuest___________________________.docx15 April 2013Page   of 1 ProQuest___________________________.docx
15 April 2013Page of 1 ProQuest___________________________.docxhyacinthshackley2629
 
Prehabilitacion cx abdominal.pdf
Prehabilitacion cx abdominal.pdfPrehabilitacion cx abdominal.pdf
Prehabilitacion cx abdominal.pdfssuserbc030e
 
Annals of Clinical and Medical Case Reports - Acmcasereport
Annals of Clinical and Medical Case Reports - AcmcasereportAnnals of Clinical and Medical Case Reports - Acmcasereport
Annals of Clinical and Medical Case Reports - Acmcasereportsemualkaira
 
A convenient clinical nomogram for small intestine adenocarcinoma
A convenient clinical nomogram for small intestine adenocarcinomaA convenient clinical nomogram for small intestine adenocarcinoma
A convenient clinical nomogram for small intestine adenocarcinomanguyên anh doanh
 
Global Journal of Perioperative Medicine
Global Journal of Perioperative MedicineGlobal Journal of Perioperative Medicine
Global Journal of Perioperative Medicinepeertechzpublication
 
Establishing and evaluating a pharmaceutical care in renal transplantation cl...
Establishing and evaluating a pharmaceutical care in renal transplantation cl...Establishing and evaluating a pharmaceutical care in renal transplantation cl...
Establishing and evaluating a pharmaceutical care in renal transplantation cl...M. Luisetto Pharm.D.Spec. Pharmacology
 
Impact of ERAS Protocol on the Post-Operative Complications in Colorectal Sur...
Impact of ERAS Protocol on the Post-Operative Complications in Colorectal Sur...Impact of ERAS Protocol on the Post-Operative Complications in Colorectal Sur...
Impact of ERAS Protocol on the Post-Operative Complications in Colorectal Sur...semualkaira
 
Impact of ERAS Protocol on the Post-Operative Complications in Colorectal Sur...
Impact of ERAS Protocol on the Post-Operative Complications in Colorectal Sur...Impact of ERAS Protocol on the Post-Operative Complications in Colorectal Sur...
Impact of ERAS Protocol on the Post-Operative Complications in Colorectal Sur...semualkaira
 
Development and Validation of a Nomogram for Predicting Response to Neoadjuva...
Development and Validation of a Nomogram for Predicting Response to Neoadjuva...Development and Validation of a Nomogram for Predicting Response to Neoadjuva...
Development and Validation of a Nomogram for Predicting Response to Neoadjuva...semualkaira
 
Predicting Diabetic Readmission Rates: Moving Beyond HbA1c
Predicting Diabetic Readmission Rates: Moving Beyond HbA1cPredicting Diabetic Readmission Rates: Moving Beyond HbA1c
Predicting Diabetic Readmission Rates: Moving Beyond HbA1cDamian R. Mingle, MBA
 
38 www.e-enm.orgEndocrinol Metab 2016;3138-44httpdx.
38 www.e-enm.orgEndocrinol Metab 2016;3138-44httpdx.38 www.e-enm.orgEndocrinol Metab 2016;3138-44httpdx.
38 www.e-enm.orgEndocrinol Metab 2016;3138-44httpdx.dessiechisomjj4
 
JASICON 2021 presentation ppt.pptx
JASICON 2021 presentation ppt.pptxJASICON 2021 presentation ppt.pptx
JASICON 2021 presentation ppt.pptxSoumyajitJana7
 
Contents lists available at ScienceDirectApplied Nursing R
Contents lists available at ScienceDirectApplied Nursing RContents lists available at ScienceDirectApplied Nursing R
Contents lists available at ScienceDirectApplied Nursing RAlleneMcclendon878
 

Similaire à Risk factors for readmission after elective colectomy postoperative complications are more important than patient and operative factors (20)

AC Chemo CRC ASCO Poster
AC Chemo CRC ASCO PosterAC Chemo CRC ASCO Poster
AC Chemo CRC ASCO Poster
 
Factors Predict Perioperative Morbidity pancreatic resection
Factors Predict Perioperative Morbidity pancreatic resectionFactors Predict Perioperative Morbidity pancreatic resection
Factors Predict Perioperative Morbidity pancreatic resection
 
Journal readingg
Journal readinggJournal readingg
Journal readingg
 
ERAS and regional anesthesia at PGA 2015
ERAS and regional anesthesia at PGA 2015ERAS and regional anesthesia at PGA 2015
ERAS and regional anesthesia at PGA 2015
 
Open Journal of Surgery
Open Journal of SurgeryOpen Journal of Surgery
Open Journal of Surgery
 
15 April 2013Page of 1 ProQuest___________________________.docx
15 April 2013Page   of 1 ProQuest___________________________.docx15 April 2013Page   of 1 ProQuest___________________________.docx
15 April 2013Page of 1 ProQuest___________________________.docx
 
Prehabilitacion cx abdominal.pdf
Prehabilitacion cx abdominal.pdfPrehabilitacion cx abdominal.pdf
Prehabilitacion cx abdominal.pdf
 
Annals of Clinical and Medical Case Reports - Acmcasereport
Annals of Clinical and Medical Case Reports - AcmcasereportAnnals of Clinical and Medical Case Reports - Acmcasereport
Annals of Clinical and Medical Case Reports - Acmcasereport
 
A convenient clinical nomogram for small intestine adenocarcinoma
A convenient clinical nomogram for small intestine adenocarcinomaA convenient clinical nomogram for small intestine adenocarcinoma
A convenient clinical nomogram for small intestine adenocarcinoma
 
Global Journal of Perioperative Medicine
Global Journal of Perioperative MedicineGlobal Journal of Perioperative Medicine
Global Journal of Perioperative Medicine
 
Establishing and evaluating a pharmaceutical care in renal transplantation cl...
Establishing and evaluating a pharmaceutical care in renal transplantation cl...Establishing and evaluating a pharmaceutical care in renal transplantation cl...
Establishing and evaluating a pharmaceutical care in renal transplantation cl...
 
ANZUP1 (dragged)
ANZUP1 (dragged)ANZUP1 (dragged)
ANZUP1 (dragged)
 
Impact of ERAS Protocol on the Post-Operative Complications in Colorectal Sur...
Impact of ERAS Protocol on the Post-Operative Complications in Colorectal Sur...Impact of ERAS Protocol on the Post-Operative Complications in Colorectal Sur...
Impact of ERAS Protocol on the Post-Operative Complications in Colorectal Sur...
 
Impact of ERAS Protocol on the Post-Operative Complications in Colorectal Sur...
Impact of ERAS Protocol on the Post-Operative Complications in Colorectal Sur...Impact of ERAS Protocol on the Post-Operative Complications in Colorectal Sur...
Impact of ERAS Protocol on the Post-Operative Complications in Colorectal Sur...
 
Development and Validation of a Nomogram for Predicting Response to Neoadjuva...
Development and Validation of a Nomogram for Predicting Response to Neoadjuva...Development and Validation of a Nomogram for Predicting Response to Neoadjuva...
Development and Validation of a Nomogram for Predicting Response to Neoadjuva...
 
American Journal of Anesthesia & Clinical Research
American Journal of Anesthesia & Clinical ResearchAmerican Journal of Anesthesia & Clinical Research
American Journal of Anesthesia & Clinical Research
 
Predicting Diabetic Readmission Rates: Moving Beyond HbA1c
Predicting Diabetic Readmission Rates: Moving Beyond HbA1cPredicting Diabetic Readmission Rates: Moving Beyond HbA1c
Predicting Diabetic Readmission Rates: Moving Beyond HbA1c
 
38 www.e-enm.orgEndocrinol Metab 2016;3138-44httpdx.
38 www.e-enm.orgEndocrinol Metab 2016;3138-44httpdx.38 www.e-enm.orgEndocrinol Metab 2016;3138-44httpdx.
38 www.e-enm.orgEndocrinol Metab 2016;3138-44httpdx.
 
JASICON 2021 presentation ppt.pptx
JASICON 2021 presentation ppt.pptxJASICON 2021 presentation ppt.pptx
JASICON 2021 presentation ppt.pptx
 
Contents lists available at ScienceDirectApplied Nursing R
Contents lists available at ScienceDirectApplied Nursing RContents lists available at ScienceDirectApplied Nursing R
Contents lists available at ScienceDirectApplied Nursing R
 

Plus de Gastroenterologia Medica Sur

caracteristicas clínicas y endoscopicas de eosinofilia esofagica y esofagitis...
caracteristicas clínicas y endoscopicas de eosinofilia esofagica y esofagitis...caracteristicas clínicas y endoscopicas de eosinofilia esofagica y esofagitis...
caracteristicas clínicas y endoscopicas de eosinofilia esofagica y esofagitis...Gastroenterologia Medica Sur
 
Esomeprazol oral vs IV postendoscópico en prevención de resangrado
Esomeprazol oral vs IV postendoscópico en prevención de resangradoEsomeprazol oral vs IV postendoscópico en prevención de resangrado
Esomeprazol oral vs IV postendoscópico en prevención de resangradoGastroenterologia Medica Sur
 
Efecto sinérgico de alcohol y tabaco en cáncer de células escamosas de esófago
Efecto sinérgico de alcohol y tabaco en cáncer de células escamosas de esófagoEfecto sinérgico de alcohol y tabaco en cáncer de células escamosas de esófago
Efecto sinérgico de alcohol y tabaco en cáncer de células escamosas de esófagoGastroenterologia Medica Sur
 
The Optimal Number of Biopsy Fragments to Establish a Morphologic Diagnosis o...
The Optimal Number of Biopsy Fragments to Establish a Morphologic Diagnosis o...The Optimal Number of Biopsy Fragments to Establish a Morphologic Diagnosis o...
The Optimal Number of Biopsy Fragments to Establish a Morphologic Diagnosis o...Gastroenterologia Medica Sur
 
The effectiveness and risks of bariatric surgery an updated systematic review...
The effectiveness and risks of bariatric surgery an updated systematic review...The effectiveness and risks of bariatric surgery an updated systematic review...
The effectiveness and risks of bariatric surgery an updated systematic review...Gastroenterologia Medica Sur
 
Effecto of linaclotide on severe abdominal symptoms in patients
Effecto of linaclotide on severe abdominal symptoms in patientsEffecto of linaclotide on severe abdominal symptoms in patients
Effecto of linaclotide on severe abdominal symptoms in patientsGastroenterologia Medica Sur
 
Barrett's esophagus with low grade dysplasia and incidence of adenocarcinoma
 Barrett's esophagus with low grade dysplasia and incidence of adenocarcinoma Barrett's esophagus with low grade dysplasia and incidence of adenocarcinoma
Barrett's esophagus with low grade dysplasia and incidence of adenocarcinomaGastroenterologia Medica Sur
 
Mucosal healing and risk for lymphoproliferative malignancy in celiac disease
Mucosal healing and risk for lymphoproliferative malignancy in celiac diseaseMucosal healing and risk for lymphoproliferative malignancy in celiac disease
Mucosal healing and risk for lymphoproliferative malignancy in celiac diseaseGastroenterologia Medica Sur
 

Plus de Gastroenterologia Medica Sur (20)

caracteristicas clínicas y endoscopicas de eosinofilia esofagica y esofagitis...
caracteristicas clínicas y endoscopicas de eosinofilia esofagica y esofagitis...caracteristicas clínicas y endoscopicas de eosinofilia esofagica y esofagitis...
caracteristicas clínicas y endoscopicas de eosinofilia esofagica y esofagitis...
 
Dietas en esofagitis eosinofílica
Dietas en esofagitis eosinofílicaDietas en esofagitis eosinofílica
Dietas en esofagitis eosinofílica
 
Tratamiento crohn
Tratamiento crohnTratamiento crohn
Tratamiento crohn
 
Cianoacrilato spray
Cianoacrilato sprayCianoacrilato spray
Cianoacrilato spray
 
Esomeprazol oral vs IV postendoscópico en prevención de resangrado
Esomeprazol oral vs IV postendoscópico en prevención de resangradoEsomeprazol oral vs IV postendoscópico en prevención de resangrado
Esomeprazol oral vs IV postendoscópico en prevención de resangrado
 
Enfermedad por úlceras pépticas
Enfermedad por úlceras pépticasEnfermedad por úlceras pépticas
Enfermedad por úlceras pépticas
 
Efecto sinérgico de alcohol y tabaco en cáncer de células escamosas de esófago
Efecto sinérgico de alcohol y tabaco en cáncer de células escamosas de esófagoEfecto sinérgico de alcohol y tabaco en cáncer de células escamosas de esófago
Efecto sinérgico de alcohol y tabaco en cáncer de células escamosas de esófago
 
The LAVENDER study
The LAVENDER studyThe LAVENDER study
The LAVENDER study
 
Complicaciones cirugia rectal en obesos
Complicaciones cirugia rectal en obesosComplicaciones cirugia rectal en obesos
Complicaciones cirugia rectal en obesos
 
Dm y pa
Dm y paDm y pa
Dm y pa
 
Dm y pa
Dm y paDm y pa
Dm y pa
 
Cepillado biliar paca colangiocarcinoma en cep
Cepillado biliar paca colangiocarcinoma en cepCepillado biliar paca colangiocarcinoma en cep
Cepillado biliar paca colangiocarcinoma en cep
 
The Optimal Number of Biopsy Fragments to Establish a Morphologic Diagnosis o...
The Optimal Number of Biopsy Fragments to Establish a Morphologic Diagnosis o...The Optimal Number of Biopsy Fragments to Establish a Morphologic Diagnosis o...
The Optimal Number of Biopsy Fragments to Establish a Morphologic Diagnosis o...
 
The effectiveness and risks of bariatric surgery an updated systematic review...
The effectiveness and risks of bariatric surgery an updated systematic review...The effectiveness and risks of bariatric surgery an updated systematic review...
The effectiveness and risks of bariatric surgery an updated systematic review...
 
Effecto of linaclotide on severe abdominal symptoms in patients
Effecto of linaclotide on severe abdominal symptoms in patientsEffecto of linaclotide on severe abdominal symptoms in patients
Effecto of linaclotide on severe abdominal symptoms in patients
 
Mortalidad y causas de muerte en Crohn
Mortalidad y causas de muerte en CrohnMortalidad y causas de muerte en Crohn
Mortalidad y causas de muerte en Crohn
 
Barrett's esophagus with low grade dysplasia and incidence of adenocarcinoma
 Barrett's esophagus with low grade dysplasia and incidence of adenocarcinoma Barrett's esophagus with low grade dysplasia and incidence of adenocarcinoma
Barrett's esophagus with low grade dysplasia and incidence of adenocarcinoma
 
Veb
VebVeb
Veb
 
Celiac disease or gluten sensitivity1
Celiac disease or gluten sensitivity1Celiac disease or gluten sensitivity1
Celiac disease or gluten sensitivity1
 
Mucosal healing and risk for lymphoproliferative malignancy in celiac disease
Mucosal healing and risk for lymphoproliferative malignancy in celiac diseaseMucosal healing and risk for lymphoproliferative malignancy in celiac disease
Mucosal healing and risk for lymphoproliferative malignancy in celiac disease
 

Dernier

Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledgeassessoriafabianodea
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxNiranjan Chavan
 
maternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalitymaternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalityhardikdabas3
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxEyobAlemu11
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
low cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxlow cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxdrashraf369
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityHarshChauhan475104
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...MehranMouzam
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Classmanuelazg2001
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsMedicoseAcademics
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxKezaiah S
 

Dernier (20)

Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
 
maternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalitymaternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortality
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptx
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
low cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxlow cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptx
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Class
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptx
 

Risk factors for readmission after elective colectomy postoperative complications are more important than patient and operative factors

  • 1. 98 DISEASES OF THE COLON & RECTUM VOLUME 57: 1 (2014) BACKGROUND: Colon resections are associated with substantial risk for morbidity and readmissions, and these have become markers for quality of care. OBJECTIVE: The purpose of this study was to determine risk factors for readmissions after elective colectomies to improve patient care and better understand the complex issues associated with readmissions. DESIGN: This was an analysis of the prospective, statewide, multicenter Michigan Surgical Quality Collaborative database. SETTINGS: The analysis was conducted at academic and community medical centers in the state of Michigan. PATIENTS: Elective laparoscopic and open ileocolic and segmental colectomies from 2008 through 2010 were included. MAIN OUTCOME MEASURES: Univariate analysis and a multivariate logistic regression model were used to determine influence of patient characteristics, operative factors, and postoperative complications on the incidence of 30-day postoperative readmission. RESULTS: The readmission rate among 4013 cases was 7.3% (N = 293). On the basis of multivariate logistic regression, the top 3 significant risk factors associated with readmission were stroke (OR, 10.0 [95% CI, 2.70–37.0]; p = 0.001), venous thromboembolism (OR, 6.5 [95% CI, 3.7–11.3]; p < 0.0001), and organ-space surgical site infection (OR, 5.6 [95% CI, 3.4–9.4]; p < 0.0001). Important factors that contributed to readmission risk but were not found to be independent predictors of readmission included diabetes mellitus, preoperative steroids, smoking, cardiac comorbidities, age >80 years, anastomotic leaks, fascial dehiscence, sepsis, pneumonia, unplanned intubation, and length of stay. LIMITATIONS: The Michigan Surgical Quality Collaborative is a large database, and true causal relations are difficult to determine; reason for readmission is not recorded in the database. CONCLUSIONS: Postoperative complications account for the majority of risk factors behind readmissions after elective colectomy, whereas preoperative risk factors have less direct influence. Current strategies addressing readmission rates should focus on reducing preventable complications. KEY WORDS: Colon resection; Complications; Postoperative readmissions, Risk factors. C olectomies are frequently performed procedures with a high risk for complications and readmis- sions.1–4 Unplanned readmissions after colon and rectal operations can have serious consequences for pa- tients4 and have a significant economic impact for health- care providers. More recently, readmissions have gained widespread interest among insurance companies, media, and politicians as a quality indicator for medical and sur- gical outcomes. With the introduction of the Hospital Readmission Reduction Program by the Centers for Medi- care & Medicaid Services in 2012, 30-day readmissions Risk Factors for Readmission After Elective Colectomy: Postoperative Complications Are More Important Than Patient and Operative Factors Therese G. Kerwel, M.D.1 2 1 Samantha K. Hendren, M.D.3 2 1 1 Division of Colon and Rectal Surgery, Spectrum Health, Grand Rapids, Michigan 2 Department of Surgery, St. Joseph Mercy Health System, Ann Arbor, Michigan 3 Department of Surgery, University of Michigan, Ann Arbor, Michigan Dis Colon Rectum 2014; 57: 98–104 DOI: 10.1097/DCR.0000000000000007 © The ASCRS 2013 Financial Disclosure: None reported. Podium presentation at the meeting of The American Society of Colon and Rectal Surgeons, Phoenix, AZ, April 27 to May 1, 2013. Correspondence: Therese G. Kerwel, M.D., 25 Michigan St NE, Suite 2200, Grand Rapids, MI 49503. E-mail: theresegannon@hotmail.com ORIGINAL CONTRIBUTION
  • 2. DISEASES OF THE COLON & RECTUM VOLUME 57: 1 (2014) 99 may also be subject to reduced reimbursement. Hospitals with higher-than-predicted rates of readmissions may face financial penalties, and almost half of large teaching hos- pitals might be subjected to these cuts.5 Because of the enormous medical and financial im- pacts of unplanned readmissions, numerous studies have attempted to define risk factors for readmissions after colon and rectal surgery. Despite numerous studies, widespread disagreement remains in the medical literature regarding whether there are modifiable risk factors for readmission or whether it is largely unavoidable.6,7 None of those stud- ies were able to delineate definitive strategies for readmis- sion reduction,8 but all of them agree that the medical and financial costs associated with this are high. Identifying modifiable and/or avoidable factors in colon and rectal surgery would have the potential to improve patient out- comes and reduce health care-related costs. The aim of this study was to identify risk factors that are independently as- sociated with readmission within 30 days of elective colec- tomy by analyzing the prospective, multicenter Michigan Surgical Quality Collaborative (MSQC) database. MATERIALS AND METHODS The MSQC is a collaboration of 52 community and aca- demic hospitals throughout the state of Michigan with the goal to improve quality and patient outcomes.9 Sixty- two percent of the participating hospitals are community based without teaching activities.9 The MSQC database is similar to the rigorously maintained American College of Surgeons’ National Surgical Quality Improvement Pro- gram (NSQIP).10,11 Collected data include >200 variables and include patient demographic characteristics and co- morbidities, preoperative and intraoperative measures, and 30-day postoperative outcomes.11 The MSQC colecto- my project involves 24 of the 52 hospitals and additionally records procedure-specific perioperative data on patients undergoing partial colectomy. Data for the MSQC are meticulously recorded by NSQIP-certified clinical nurse reviewers at each participating hospital. In case of miss- ing or inconsistent data, the data abstractors communi- cate directly with the operating surgeon. Readmissions are tracked across all of the MSQC-participating hospitals and are not limited to the hospital where the patient un- derwent surgery. All of the cases of elective laparoscopic and open il- eocolic and segmental colectomies included as part of the MSQC colectomy project from June 2008 through Novem- ber 2010 were eligible for inclusion in our analysis. These operations were defined by Current Procedural Terminol- ogy codes 44140 and 44160 (open colectomy), as well as 44204 and 44205 (laparoscopic colectomy). The MSQC database excludes patients with age <18 years, pregnant women, trauma patients, and patients with ASA classes 5 and 6. Operations resulting in the creation of an ostomy, rectal resections, or low anastomoses are not included in the MSQC colectomy project. In addition, cases with com- plete obstruction or perforation, as well as any emergent cases, were also excluded from this study, because these are not elective and risk factors are not modifiable. To determine risk factors independently associated with readmission within 30 days of the index operation, patient characteristics, operative factors, and postopera- tive complications recorded in the MSQC database were first subjected to univariate analysis, determining the rela- tionship of each variable to 30-day readmission. This was followed by a multivariate logistic regression model, of both preoperative and postoperative variables, which in- cluded all of the variables with a p value of <0.10.Variables with significance on each multivariate logistic regression model were then entered into a final multivariate logistic regression model that combined preoperative and postop- erative variables to determine their independent influence on the incidence of 30-day postoperative readmission. RESULTS From June 2008 through November 2010, 4013 cases met inclusion criteria. Patient demographic characteristics are shown in Table 1. Their average age was 64.2±15.0 years with a mean BMI of 28.5±8.3. The readmission rate among these patients was 7.3% (N = 292). Table 2 lists the preoperative variables studied. Uni- variate analysis demonstrated a host of preoperative factors with associations to readmission: 1) ASA class 4 (p = 0.02), 2) being functionally dependent (either par- tial or total, p < 0.0001), 3) diabetes mellitus (p = 0.04), 4) hypertension (p = 0.003), 5) severe COPD (p = 0.02), 6) preoperative dyspnea (p = 0.001), 7) presence of an open wound (p = 0.011), 8) steroids (p < 0.0001), 9) TABLE 1. Demographics Entire cohort (N = 4013) Readmit (N = 292) No readmit (N = 3721) p N, % (n) 100 (4013) 7.28 (292) 92.72 (3721) Age (mean ± SD), y 64.2±15.0 65.0±16.0 64.2±15.0 0.38 Age ≥80 y, % (n) 16.7 (672) 20.9 (61) 16.4 (611) 0.06 Men, % (n) 47.7 (1914) 51.0 (149) 47.4 (1765) 0.25 BMI, mean ± SD 28.5±8.3 28.7±6.9 28.5±8.4 0.26 Black, % (n) 11.3 (452) 12.0 (35) 11.2 (417) 0.70
  • 3. KERWEL ET AL: RISK FACTORS FOR POSTOPERATIVE READMISSION100 known bleeding disorder (including congenital clotting disorders and chronic anticoagulation, p < 0.0001), and 10) anemia (hematocrit <30%, p = 0.04). The readmis- sion group was found to have, on average, more comor- bid conditions as defined by MSQC than the no-readmit group: 2.06±1.80 vs 1.57±1.50 (p = 0.0003). See the bottom of Table 2 for a definition of these comorbid con- ditions. A multiple logistic regression analysis of the pre- operative variables with a p value of ≤0.10 was performed to determine independent preoperative risk factors for readmission. The only significant variable resulting from this analysis was chronic preoperative steroid use (OR, 1.9 [95% CI, 1.14–3.19]; p = 0.014). Tables 3 and 4 show preoperative laboratory data and surgical variables studied. Factors on univariate analysis that were found to have an association with readmission are anemia (p = 0.04) and wound class 4 (p = 0.007). The readmission group also had more intraoperative blood loss than the no-readmit group (0.047). Laparoscopy showed a trend with decreased readmission rates, but this did not reach statistical significance. Wound class 4 was included in the analysis of preoperative variables and found to be an independent predictor of readmission (OR, 1.15; p = 0.0005) Table 5 shows the postoperative outcomes studied. The association between complications and readmission is striking from a statistical standpoint, with the major- ity of the complications being highly statistically signifi- cant for their association with readmission. Univariate analysis showed the following complications to be sig- nificant: 1) return to the operating room within 30 days (readmissions, 22.3%; no readmission, 3.6%; p < 0.0001), 2) anastomotic leak (12.8% vs 2.1%; p < 0.0001), 3) pro- longed ileus (21.4% vs 6.1%; p < 0.0001), 4) sepsis (14.7% TABLE 2. Preoperative variables and risk factors Entire cohort (N = 4013) Readmit (N = 292) No readmit (N = 3721) p Total risk factors, mean ± SDa 1.78±1.7 2.06±1.8 1.57±1.5 <0.0001 Smoker, % (n) 18.7 (744) 12.1 (35) 19.2 (709) 0.004 Alcohol use, % (n) 3.2 (127) 2.1 (6) 3.3 (121) 0.38 Functionally dependent, % (n) 4.8 (193) 10.3 (30) 4.4 (163) <0.0001 ASA, % (n) 1 2.7 (108) 2.4 (7) 2.7 (101) 1.00 2 50.3 (2020) 46.2 (135) 50.7 (1885) 0.13 3 42.6 (1708) 44.2 (129) 42.4 (1579) 0.58 4 4.3 (174) 7.2 (21) 4.1 (153) 0.02 Hypertension, % (n) 56.4 (2245) 63.4 (184) 55.8 (2061) 0.003 Diabetes mellitus, % (n) 17.7 (709) 21.6 (63) 17.4 (646) 0.04 Dyspnea, % (n) 16.3 (649) 21.4 (62) 15.9 (587) 0.001 Cardiac disease, % (n) 13.9 (552) 17.2 (50) 13.6 (502) 0.09 Severe COPD, % (n) 5.8 (233) 8.6 (25) 5.6 (208) 0.016 CVA, % (n) 5.0 (200) 5.9 (17) 5.0 (183) 0.40 Bleeding disorder, % (n) 4.2 (168) 7.9 (23) 3.9 (145) <0.0001 TIA, % (n) 4.0 (160) 4.8 (14) 4.0 (146) 0.44 Steroid use, % (n) 3.7 (149) 7.6 (22) 3.4 (127) <0.0001 10% weight loss, % (n) 3.3 (131) 3.1 (9) 3.3 (122) 1.00 Disseminated cancer, % (n) 2.6 (102) 2.4 (7) 2.6 (95) 1.00 Open wound, % (n) 1.1 (42) 2.4 (7) 0.9 (35) 0.011 DNR, % (n) 1.0 (38) 1.4 (4) 0.9 (34) 0.35 CHF within 30 days, % (n) 1.0 (41) 1.7 (5) 1.0 (36) 0.12 PVD, % (n) 1.0 (40) 1.7 (5) 0.9 (35/3694) 0.21 Dialysis dependence, % (n) 0.8 (31) 0.7 (2) 0.8 (29/3694) 1.00 Ascites, % (n) 0.4 (16) 0.0 (0) 0.4 (16/3694) 0.62 Delirium, % (n) 0.2 (7) 0.3 (1) 0.2 (6/3694) 0.41 DNR = do not resuscitate; COPD = chronic obstructive pulmonary disease; CHF = congestive heart failure; PVD = peripheral vascular disease; TIA = transient ischemic attack; CVA = cerebrovascular accident. Bold p values indicate significance. a Subjects receive 1 point for each of the following preoperative risk factors as defined by the Michigan Surgical Quality Collaborative: diabetes mellitus, preoperative sepsis, current smoker, >2 alcoholic drinks per day within 2 weeks, DNR status, ventila- tor dependence within 48 hours, severe COPD, current pneumonia, ascites within 30 days, esophageal varices, CHF within 30 days, history of myocardial infarction in the past 6 months, previous percutaneous coronary intervention/percutaneous transluminal coronary angioplasty, previous cardiac surgery, angina within 30 days, hypertension requiring medication, history of revasculariza- tion or amputation for PVD, rest pain/gangrene, acute renal failure within 24 hours, dialysis dependence, impaired sensorium within 48 hours, coma, hemiplegia/hemiparesis, history of TIAs, CVA with or without residual neurologic deficit, tumor involving central nervous system, paraplegia/paraparesis, quadriplegia/quadriparesis, disseminated cancer, open wound, steroid use for chronic condition, >10% loss of body weight in the last 6 months, ≥4 packed red blood cells preoperatively within 72 hours, chemotherapy or radiotherapy within 90 days, sepsis within 48 hours, pregnancy, or previous operation within 30 days.
  • 4. DISEASES OF THE COLON & RECTUM VOLUME 57: 1 (2014) 101 vs 3.1%; p < 0.0001), 5) septic shock (4.8% vs 1.0%; p < 0.0001), 6) pneumonia (5.5% vs 2.1%; p < 0.0001), 7) unplanned intubation (5.8% vs 2.4%; p < 0.0001), 8) or- gan space surgical site infection ((SSI) 16.4% vs 1.6%; p < 0.0001), 9) venous thromboembolism (9.2% vs 1.1%; p < 0.0001), 10) Clostridium difficile colitis (5.5% vs 1.1%; p < 0.0001), 11) mechanical bowel obstruction (6.6% vs 0.7%; p < 0.0001), 12) wound dehiscence (2.4% vs 0.8%; p = 0.010), 13) acute myocardial infarction (3.1% vs 0.5%; p < 0.0001), 14) cardiac arrest requiring cardiopulmonary resuscitation (1.7% vs 0.6%; p = 0.024), 15) stroke (1.7% vs 0.2%; p < 0.0001), 16) progressive renal insufficiency (4.8% vs 0.5%; p < 0.0001), 17) superficial SSI (14.0% vs 5.1%; p < 0.0001), and 18) urinary tract infection (6.5% vs 2.2%; p < 0.0001). The postoperative variables with a p value of ≤0.10 were evaluated in a multiple logistic regression analysis to determine which variables were independent risk fac- tors. These are reoperation within 30 days, organ space SSI, venous thromboembolism, Clostridium difficile coli- tis, acute myocardial infarction, stroke, mechanical bowel obstruction, prolonged ileus, urinary tract infection, and superficial SSI. These postoperative variables were then analyzed with preoperative steroid use in a combined multilogistic regression analysis. This then identified risk factors that independently predict readmission (Table 6): 1) postoperative stroke (OR, 10.01; p = 0.001), 2) postop- erative venous thromboembolism (OR, 6.51; p < 0.0001), 3) organ space SSI (OR, 5.6; p < 0.0001), 4) postopera- tive progressive renal insufficiency (OR, 3.95; p = 0.001), 5) postoperative Clostridium difficile colitis (OR, 3.61; p < 0.0001), 6) reoperation within 30 days (OR, 3.12; p < 0.0001), 7) postoperative myocardial infarction (OR, 2.92; p = 0.03), 8) postoperative mechanical bowel obstruction (OR, 2.92; p = <0.0001), 9) superficial SSI (OR, 2.78; p < 0.0001), 10) prolonged ileus (OR, 2.23; p < 0.0001), and 11) urinary tract infection (OR, 1.9; p = 0.008). Preopera- tive steroid use was no longer a significant risk factor when analyzed with postoperative complications. DISCUSSION Major bowel resections have a high rate of patient re- admission, with the majority (82%) occurring in the first 30 days postoperatively.12,13 Thirty-day readmission rates have become a marker of surgical quality and pos- sible grounds for reimbursement penalties. As Centers for Medicare & Medicaid Services attempts to involve read- missions as a component of the total cost of an episode of care, it is crucial that surgeons identify risk factors associ- ated with readmissions.14 This analysis of a large series of elective colectomies in multiple hospitals across the state of Michigan demonstrated a readmission rate of 7.3%. Although these results compare very favorably with fre- quently reported 30-day readmission rates between 11.0% and 13.7% after colorectal surgery,1,2,4 they confirm that TABLE 4. Surgical variables Cohort Readmit No readmit p Type of surgery Partial colectomy, % (n) 32.3 (1295) 36.6 (107) 31.9 (1188) 0.2 Right hemicolectomy, % (n) 19.9 (799) 19.9 (58) 19.9 (741) 1.00 Laparoscopic partial colectomy, % (n) 33.7 (1353) 30.1 (88) 34.0 (1265) 0.20 Laparoscopic right hemicolectomy, % (n) 14.1 (565) 13.3 (39) 14.1 (526) 0.79 Laparoscopy, % (n) 47.8 (1918) 43.5 (127) 48.1 (1791) 0.13 Intraoperative blood loss (mean ± SD), mL 137±220 156±180 135±171 0.047 Wound class, % (n) 2 86.6 (3474) 81.2 (237) 87.0 (3237) 0.007 3 9.9 (398) 12.3 (36) 9.7 (362) 0.16 4 3.5 (139) 6.5 (19) 3.2 (120) 0.0069 Bold p values indicate significance. TABLE 3. Selected laboratory values Cohort Readmit No readmit p Anemia (Hct <30%), % (n) 9.4 (362) 12.5 (35) 9.2 (327) 0.036 Mean Hct (mean ± SD), % 38.0±5.8 37.2±5.9 38.1±5.8 0.013 Preoperative glucose (mean ± SD), mg/dL 111±38 114±37 111±38 0.218 Intraoperative glucose, mean ± SD 158±58 166±51 157±59 0.47 Glucose POD1, mean ± SD 143±44 147±52 143±43 0.17 Glucose POD2, mean ± SD 126±37 128±38 126±37 0.46 Hct = hematocrit; POD = postoperative day. Bold p values indicate significance.
  • 5. KERWEL ET AL: RISK FACTORS FOR POSTOPERATIVE READMISSION102 readmissions are indeed a problem. Although the 30-day mortality rate in patients who were readmitted was not significantly higher than in patients who did not return to the hospital (2.1% vs 1.7%; p = 0.64), other studies have shown worse long-term outcomes at 1 year, especially among cancer patients.1,4 In our multivariate analysis, we demonstrated that postoperative complications accounted for the majority of risk factors that were independently associated with 30- day readmissions. Although not all postoperative compli- cations are avoidable, this factor may be more amenable to strategies aimed to reduce preventable complications than patient factors and comorbidities, because many patient factors cannot be modified in the preoperative period before colon resection. The strong association between readmissions and postoperative complications has been shown before in other studies.1,2,15,16 Of interest, the article by Kassin et al16 reached the same conclusions that we have using a similar analysis with similar methodology for gen- eral surgery patients. The complications with the highest incidence in our cohort were prolonged ileus (7.2%), superficial SSI (5.7%), sepsis (4.0%), anastomotic leak (3.3%), and organ space SSI (2.6%). All of the other complications related to read- missions had an incidence of well below 3%. These data suggest that an effort to reduce those complications might reduce readmission rates. A reduction in prolonged ileus has been shown with narcotic-sparing enhanced recov- ery pathways (ERPs) and use of minimally invasive tech- niques.17–19 As more high-quality studies become available TABLE 5. Postoperative outcomes Cohort Readmits No readmits p In-hospital death, % (n) 1.7 (70) 2.1 (6) 1.7 (64) 0.64 Prolonged ileus, % (n) 7.2 (285) 21.4 (62) 6.1 (223) <0.0001 SSI–superficial, % (n) 5.7 (230) 14.0 (41) 5.1 (189) <0.0001 Return to OR within 30 days, % (n) 4.9 (197) 22.3 (66) 3.6 (132) <0.0001 Sepsis, % (n) 4.0 (159) 14.7 (43) 3.1 (116) <0.0001 Anastomotic leak, % (n) 3.3 (113) 12.8 (37) 2.1 (76) <0.0001 Unplanned intubation, % (n) 2.6 (105) 5.8 (17) 2.4 (88) <0.0001 SSI–organ space, % (n) 2.6 (106) 16.4 (48) 1.6 (58) <0.0001 UTI, % (n) 2.5 (100) 6.5 (19) 2.2 (81) <0.0001 Pneumonia, % (n) 2.4 (95) 5.5 (16) 2.1 (79) <0.0001 VTE, % (n) 1.7 (69) 9.2 (27) 1.1 (42) <0.0001 Clostridium difficile colitis, % (n) 1.4 (58) 5.5 (16) 1.1 (42) <0.0001 Septic shock, % (n) 1.2 (50) 4.8 (14) 1.0 (36) <0.0001 Mechanical obstruction, % (n) 1.1 (43) 6.6 (19) 0.7 (24) <0.0001 Wound dehiscence, % (n) 1.0 (39) 2.4 (7) 0.8 (32) 0.010 Progressive renal insufficiency, % (n) 0.8 (33) 4.8 (14) 0.5 (19) <0.0001 SSI–deep space, % (n) 0.7 (30) 1.0 (3) 0.7 (27) 0.48 Acute myocardial infarction, % (n) 0.7 (29) 3.1 (9) 0.5 (20) <0.0001 Cardiac arrest, % (n) 0.7 (28) 1.7 (5) 0.6 (23) 0.024 Acute renal failure, % (n) 0.6 (23) 1.0 (3) 0.5 (20) 0.23 Stroke, % (n) 0.3 (11) 1.7 (5) 0.2 (6) <0.0001 Median length of stay, days 5 (0–82) 6 (1–58) 5 (0–82) SSI = surgical site infection; OR = operating room; UTI = urinary tract infection; VTE = venous thromboembolism. Bold p values indicate significance. TABLE 6. Risk factors for readmission based on multivariate analysis OR 95% CI, lower 95% CI, upper p Postoperative CVA 10.0 2.70 37.0 0.001 Postoperative VTE 6.51 3.75 11.31 <0.0001 Organ space SSI 5.63 3.38 9.37 <0.0001 Postoperative progressive renal insufficiency 3.95 1.74 8.94 0.001 Postoperative Clostridium difficile colitis 3.61 1.81 7.18 <0.0001 Postoperative reoperation 3.12 2.03 4.79 <0.0001 Superficial SSI 2.78 1.87 4.16 <0.0001 Postoperative mechanical bowel obstruction 2.92 1.35 6.33 0.007 Postoperative acute myocardial infarction 2.92 1.12 7.57 0.028 Prolonged ileus 2.23 1.53 3.24 <0.0001 Postoperative UTI 1.89 1.05 3.38 0.033 CVA = cerebrovascular accident; SSI = surgical site infection; UTI = urinary tract infection; VTE = venous thromboembolism. Bold p values indicate significance.
  • 6. DISEASES OF THE COLON & RECTUM VOLUME 57: 1 (2014) 103 demonstrating the superiority of ERPs over the conven- tional postoperative management of colorectal patients, a continuing decrease in prolonged ileus may be seen. How- ever, reducing the rate of superficial SSIs has proven to be a difficult task despite tremendous effort on the part of physi- cians and hospitals. Although process measures such as the Surgical Care Improvement Program were introduced to reduce infectious complications after surgery and are now considered standard of care, the ability of these measures to actually improve outcomes is highly controversial.15,20,21 This leads to the more general question of how to ap- proach complications in colorectal surgery that are difficult to impact.Similar to superficial SSIs,anastomotic leaks have been studied extensively, but undisputed risk factors and strategies to avoid them, short of avoiding an anastomosis, remain elusive.Penalization for readmission related to some complications may, therefore, not be the right approach. Notably, several important patient-related factors, such as age,diabetes mellitus,and cardiac comorbidities were not found to be independent predictors of 30-day readmission, although they must contribute to some degree by increasing the risk for complications. In contrast to our study, Schnei- der et al1 found patient-related factors such as older age and severity of comorbidities to be important predictors, and Wick et al2 found an association between a longer initial length of stay (LOS (>7 days)) and readmission. Although we did not find that older age was a risk factor, our data do indicates that accumulating risk factors puts a patient at risk for readmission (OR, 1.22), although not to the degree that postoperative complications do (Table 6). The chain of events among preoperative risk factors, postoperative com- plications, and readmission is difficult to unravel. For many patient factors and complications, this degree of correlation between preoperative risk factors and postoperative com- plications will always remain unclear, and any analysis of a database that collects preoperative and postoperative data, such as the NSQIP, does not allow us to completely unravel this chain of events.This is a limitation that our study shares with other recent similar analyses1-3 on readmission, as well as most studies involving the NSQIP in general.1,16,22 The commonly used methodology of performing univariate fol- lowed by multivariate analysis aims to reduce confounding factors but cannot completely exclude them. Our results did not demonstrate an association be- tween LOS and readmission rate. This finding is particu- larly interesting in light of the increasing introduction of ERPs, which have been shown to lead to a reduction in LOS but have raised concerns about increased complica- tions and readmission rates. These findings are consistent with an increasing number of studies that confirm the safety of ERPs.3,8,17–19,23 When discussing these findings, several strengths and limitations of our study methodology have to be consid- ered. Our results are derived from a thoroughly main- tained multicenter database that adheres to strict data recording and quality standards. We analyzed a compre- hensive list of variables for their association with post- operative readmission, many of which would be difficult or impossible to assess in a randomized clinical trial. Be- cause of its inclusion of a wide variety of hospitals, from a rural community to large university hospitals, our patient population may be considered representative of a real- world patient care setting. Nevertheless, this study comes with the limitations associated with any database analy- sis, and true causal relations cannot be determined. The MSQC database does not record reasons for readmissions within 30 days, and, therefore, it is not possible to deter- mine whether some readmissions were planned. In addi- tion, our findings might be influenced by current surgical practices in the state of Michigan, which may limit their national generalizability. In summary, postoperative complications account for the majority of risk factors behind readmissions after elective colectomy, whereas preoperative, patient-related risk factors have less direct influence. Current strategies addressing readmission rates should focus on reducing preventable complications while still accepting that much may not be completely avoidable. In addition, the issue of readmission may need to be refocused on defining accept- able rates of complications instead of widespread policies aimed at penalizing all readmissions. REFERENCES 1. Schneider EB, Hyder O, Brooke BS, et al. Patient readmission and mortality after colorectal surgery for colon cancer: impact of length of stay relative to other clinical factors. J Am Coll Surg. 2012;214:390–398. 2. Wick EC, Shore AD, Hirose K, et al. Readmission rates and cost following colorectal surgery. Dis Colon Rectum. 2011;54:1475–1479. 3. Hendren S, Morris AM, Zhang W, Dimick J. Early discharge and hospital readmission after colectomy for cancer. Dis Colon Rec- tum. 2011;54:1362–1367. 4. Greenblatt DY, Weber SM, O’Connor ES, LoConte NK, Liou JI, Smith MA. Readmission after colectomy for cancer predicts one-year mortality. Ann Surg. 2010;251:659–669. 5. Joynt KE, Jha AK. Characteristics of hospitals receiving pen- alties under the Hospital Readmissions Reduction Program. JAMA. 2013;309:342–343. 6. Joynt KE, Jha AK. Thirty-day readmissions: truth and conse- quences. N Engl J Med. 2012;366:1366–1369. 7. van Walraven C, Bennett C, Jennings A, Austin PC, Forster AJ. Proportion of hospital readmissions deemed avoidable: a sys- tematic review. CMAJ. 2011;183:E391–E402. 8. O’Brien DP, Senagore A, Merlino J, Brady K, Delaney C. Predic- tors and outcome of readmission after laparoscopic intestinal surgery. World J Surg. 2007;31:2430–2435. 9. Campbell DA Jr, Kubus JJ, Henke PK, Hutton M, Englesbe MJ. The Michigan Surgical Quality Collaborative: a legacy of Shukri Khuri. Am J Surg. 2009;198(suppl):S49–S55.
  • 7. KERWEL ET AL: RISK FACTORS FOR POSTOPERATIVE READMISSION104 10. Fink AS, Campbell DA Jr, Mentzer RM Jr, et al. The National Surgical Quality Improvement Program in non-veterans ad- ministration hospitals: initial demonstration of feasibility. Ann Surg. 2002;236:344–353. 11. Khuri SF, Daley J, Henderson W, et al. The Department of Vet- erans Affairs’ NSQIP: the first national, validated, outcome- based, risk-adjusted, and peer-controlled program for the measurement and enhancement of the quality of surgical care. National VA Surgical Quality Improvement Program. Ann Surg. 1998;228:491–507. 12. Azimuddin K, Rosen L, Reed JF 3rd, Stasik JJ, Riether RD, Khubchandani IT. Readmissions after colorectal surgery cannot be predicted. Dis Colon Rectum. 2001;44:942–946. 13. Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med. 2009;360:1418–1428. 14. Birkmeyer JD, Gust C, Baser O, Dimick JB, Sutherland JM, Skin- ner JS. Medicare payments for common inpatient procedures: implications for episode-based payment bundling. Health Serv Res. 2010;45:1783–1795. 15. Berenguer CM, Ochsner MG Jr, Lord SA, Senkowski CK. Im- proving surgical site infections: using National Surgical Quality Improvement Program data to institute Surgical Care Improve- ment Project protocols in improving surgical outcomes. J Am Coll Surg. 2010;210:737–41, 741. 16. Kassin MT, Owen RM, Perez SD, et al. Risk factors for 30-day hospital readmission among general surgery patients. J Am Coll Surg. 2012;215:322–330. 17. Jorgensen H, Wetterslev J, Moiniche S, Dahl JB. Epidural lo- cal anaesthetics versus opioid-based analgesic regimens on postoperative gastrointestinal paralysis, PONV and pain after abdominal surgery. Cochrane Database Syst Rev. 2000;(4):CD001893. 18. Li MZ, Xiao LB, Wu WH, Yang SB, Li SZ. Meta-analysis of lapa- roscopic versus open colorectal surgery within fast-track peri- operative care. Dis Colon Rectum. 2012;55:821–827. 19. Vlug MS, Wind J, Hollmann MW, et al.; LAFA study group. Laparoscopy in combination with fast track multimodal man- agement is the best perioperative strategy in patients undergo- ing colonic surgery: a randomized clinical trial (LAFA-study). Ann Surg. 2011;254:868–875. 20. Garcia N, Fogel S, Baker C, Remine S, Jones J. Should com- pliance with the Surgical Care Improvement Project (SCIP) process measures determine Medicare and Medicaid reim- bursement rates? Am Surg. 2012;78:653–656. 21. Ingraham AM, Cohen ME, Bilimoria KY, et al. Associa- tion of surgical care improvement project infection-related process measure compliance with risk-adjusted outcomes: implications for quality measurement. J Am Coll Surg. 2010;211:705–714. 22. Schneider EB, Hyder O, Wolfgang CL, et al. Patient readmission and mortality after surgery for hepato-pancreato-biliary malig- nancies. J Am Coll Surg. 2012;215:607–615. 23. KolozsvariNO,CaprettiG,KanevaP,etal.Impactof anenhanced recovery program on short-term outcomes after scheduled lap- aroscopic colon resection. Surg Endosc. 2013;27:133–138.